Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease.
Experimental autoimmune encephalomyelitis models are used to analyze the generation and organization of the myelin-specific autoimmune repertoire, and potential immunoregulatory loops preventing spontaneous activation of encephalitogenic T cells. These lymphocytes are profoundly modulated by infectious agents, which may trigger, or more commonly, prevent experimental autoimmune encephalomyelitis. The development and resolution of the pathogenic central nervous system infiltrations is controlled by locally produced cytokines that cause recruitment of infiltrate cells, and their disappearance. Several of the new findings seem now to be applicable for therapeutic strategies, especially with the aim of interfering with immunospecific recognition steps involved in disease generation.
Wekerle
H
H
Max-Planck-Institut for Psychiatry, Martinsried, Germany.
D000818:Animals; D017209:Apoptosis; D002493:Central Nervous System Diseases / Q000276:immunology*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D007167:Immunotherapy; D007239:Infections / Q000276:immunology; D009185:Myelin Proteins / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D013601:T-Lymphocytes / Q000502:physiology
D009185:Myelin Proteins; D011948:Receptors, Antigen, T-Cell